Figure 1.
Summary of genomic sequencing of FA-LBCL. Cases of FA-LBCL showed frequent mutations with immune surveillance (HLA-B, HLA-C, CD58), histone modification genes, JAK/STAT pathway, NF-κB, and tumor suppressor genes, particularly PTEN. Dec, decreased; MCD, MYD88 and CD79B group; Neg, negative; Pos, positive.

Summary of genomic sequencing of FA-LBCL. Cases of FA-LBCL showed frequent mutations with immune surveillance (HLA-B, HLA-C, CD58), histone modification genes, JAK/STAT pathway, NF-κB, and tumor suppressor genes, particularly PTEN. Dec, decreased; MCD, MYD88 and CD79B group; Neg, negative; Pos, positive.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal